ERLOTINIB 150 mg/1 (Erlotinib TABLET, FILM COATED) 150 mg/1

Erlotinib 150 mg tablets are a targeted therapy used in cancer treatment. This oral medication is designed to inhibit specific proteins that contribute to cancer cell growth.

Strength

150 mg/1

Pack Size

1 BOTTLE in 1 CARTON (31722-265-30) / 30 TABLET, FILM COATED in 1 BOTTLE

Manufacturer / TM Owner

Camber Pharmaceuticals, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Erlotinib is primarily used in the treatment of certain types of cancer, such as non-small cell lung cancer and pancreatic cancer. It works by targeting and inhibiting the epidermal growth factor receptor (EGFR), which can help slow down the growth and spread of cancer cells. Patients often wonder, 'What is Erlotinib used for?' and the answer lies in its role as a targeted therapy for these specific cancer types.

Side Effects

Common effects of Erlotinib may include skin rash, diarrhea, and fatigue. Some patients may also experience loss of appetite or nausea. These effects can vary from person to person and are not experienced by everyone who takes the medication.

Precautions & Warnings

Erlotinib should be handled with care and stored as directed. It is important to follow the advice of a healthcare provider regarding the use of this medication. Patients should inform their healthcare provider about any other medications they are taking to avoid potential interactions.

Avoid Interactions

Erlotinib may interact with certain medications, including those that are metabolized by the liver enzyme CYP3A4. It is also advisable to avoid grapefruit and grapefruit juice, as they can affect the metabolism of Erlotinib. Always consult a healthcare provider before starting or stopping any medication.

Frequently Asked Questions

Erlotinib is used in the treatment of certain types of cancer, such as non-small cell lung cancer and pancreatic cancer.

Erlotinib is typically taken orally, usually once daily. It should be taken on an empty stomach, at least one hour before or two hours after a meal.

Common side effects may include skin rash, diarrhea, fatigue, loss of appetite, and nausea.

Erlotinib may interact with certain medications, so it is important to consult a healthcare provider before combining it with other drugs.

The safety of Erlotinib for long-term use should be discussed with a healthcare provider, as it depends on individual health conditions and treatment plans.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.